Bristol Myers Squibb
OPDUALAG
Manufacturer:
Bristol Myers Squibb
Name:
OPDUALAG
Category:
J Code
HCPCS:
J9298
NDC(s):
00003-7125-11,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
OPDUALAG is a Cancer drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J9298 is aligned to the drug OPDUALAG.
Opdualag belongs to the group of drugs known as antineoplastic combinations and is used to treat certain types of cancer. This drug is a combination two different medications known as nivolumab and relatlimab. Opdualag is administered to the patient via intravenous infusion over the course of 30 minutes. Opdualag is a branded drug manufactured by the Bristol-Myers Squibb Company. Patient assistance programs for Opdualag can be found through Bristol-Myers Squibb’s Access Support here https://www.bmsaccesssupport.bmscustomerconnect.com/patient.